This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Poliomyelitis
and you are
between 54 and 75
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The trial is a phase III, non-inferiority, observer-blind, randomised, active controlled, multicentre clinical trial with 2 parallel groups: IPV-Al SSI (investigational vaccine) and IPV SSI (comparator vaccine). The vaccines will be administered at 2, 4 and 6 months of age.

Provided treatments

  • Biological: IPV-Al SSI
  • Biological: IPV SSI
Tris trial is registered with FDA with number: NCT03025750. The sponsor of the trial is Statens Serum Institut and it is looking for 800 volunteers for the current phase.
Official trial title:
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine, IPV-Al SSI, in Comparison to Non-adjuvanted Full Dose IPV SSI, in Infants Vaccinated at 2, 4 and 6 Months of Age